PL
PL · PL · PL-100323102
Revinty Ellipta
ATC R03AK10
Last synced from URPL (Poland) on
Identification
ManufacturerGlaxoSmithKline (Ireland) Limited
CountryPL (PL)
ATC codeR03AK10
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Proszek do inhalacji, podzielony",
"source": "urpl",
"strength": "184 mcg + 22 mcg",
"packaging": "Rp ¦ EU/1/14/929/006 ¦ 103040\n3 inhalatory 30 dawek\nRp ¦ EU/1/14/929/004 ¦ 103041\n1 inhalator 14 dawek\nRp ¦ EU/1/14/929/005 ¦ 103042\n1 inhalator 30 dawek",
"substance": "Fluticasoni furoas 184 mcg + Vilanterolum 22 mcg",
"common_name": "Fluticasoni furoas + Vilanterolum",
"pl_product_id": "100323102",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code R03AK10.
Access this data programmatically
Query Revinty Ellipta and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.